PAR 0.00% 25.5¢ paradigm biopharmaceuticals limited..

The game that is trading, page-6

  1. 4,013 Posts.
    lightbulb Created with Sketch. 473
    Well i was very suspicious they ( trader b artist ) was selling stock they didnt own because it was as posted before way way over top 5 or so holders in nominees under paul R .
    so where wad the stick coming from ?
    they couldnt borrow that much and i was sure paul wouldnt give it to them

    so they were playing on the chit / slate etc using t plus two netting allowances and carrying the liability to deliver knowing they couldnt deliver
    so i bought in in stages during the fall especially ramping up yesterday after being a bit too early at 3.11 3.04 then 2.90
    as the day unfolded i saw that this was just a play and bought 65,000 all up most at 2.75
    great plAy for me given i wanted to top up and never expected these prices ! I bought my first 5000 at 3.58 after all last week !
    all i can do is share my experience and thought orocess with you so you can assess the situation better next time if you can take something away from my trade experience here
    by the way im not giving them back for years and they still need to buy a lot more to balance their non deliverable sales designed to shake the tree and reaccumulate at a handsome profit for no real outlay
    looks like they balanced off the dY before yesterday but given t plus two delivery deadline they need to nett off by buying or turn up with stock tuesday
    so ... if im right... expect a strong need to buy a few more millions monday !
    dont feed them enjoy their squeeze!!!


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
0.000(0.00%)
Mkt cap ! $89.19M
Open High Low Value Volume
26.0¢ 26.0¢ 25.0¢ $110.6K 431.0K

Buyers (Bids)

No. Vol. Price($)
3 94172 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 30859 5
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.